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T O  A W A K E  A  SLEEPING BEAUTY
John Wallwork, B.Sc.
Every year over 1,000 hospital admissions for 
accidental poisoning, attem pted suicide, or 
drug overdosage occur in this city and there 
is no doubt that the size of this problem is 
increasing.
A  large variety of drugs are taken and the 
specific treatment of the more common 
poisonings is adequately dealt with in an ex­
cellent monograph of M athew and Lawson. 
It will help however to consider some general 
principles of how to tackle the acute problem 
clinically. Y o u  can :
(1) Prevent the drug entering the body’s 
circulation (stomach washouts)
(2) Prevent the drug reaching its site of 
action once in the body
(3) Prevent the drug from exerting its effect 
at this site by
(a) direct com petitive inhibition
(b) providing alternative metabolic 
pathways to overcome drug action
(4) Enhance the rate of drug metabolism
(5) Rem ove the drug from body— (diuresis, 
dialysis).
O f these methods, the first, and the last to 
a lesser extent, is widely used in practice in 
this country. Again I refer you to M athew ’s 
book for the details.
I am interested in the third of these, that 
is to prevent the drug from exerting its effect 
at its site of action by providing alternative 
m etabolic pathways, with particular reference 
to barbiturate poisoning, which constitutes the 
largest single group of agents encountered in 
clinical practice.
Before we can antagonise a drug’s action in 
this way we must know where that site of 
action is, and how the drug works.
L et us look at a little simple biochemistry.
T h e main biochemical pathway for the pro­
duction of energy is the metabolism of glucose. 
Represented in a simplified form.
Glycolysis -> Krebs cycle E.T. Chain —> Energy.
Theories concerning the m ode of action of 
barbiturates on this system have varied. Early 
work by Brody and Bain suggested that the 
action of barbiturates was mediated by an un­
coupling of oxidative phosphorylation. How­
ever Aldridge and Parker (1960) showed that 
inhibition of respiration occurred w ithout un­
coupling, in liver mitochondria; more import­
ant from our point of view, they also showed 
that the inhibition produced by barbiturates 
on the respiration of mitochondria, did not 
occur when sucoinate was used as substrate 
instead of glucose. It was concluded that the 
block must occur somewhere before the entry 
of succinate into the metabolic process.
Elaborate techniques used by Chance and 
Hollinger in 1965 corroborated this work.
Imagine the process as a production line 
with substrate in a reduced form at the left 
and products in oxidised forms to the right. 
If we stop this continuous process somewhere 
in the middle, there will be a build up of re­
duced substances to the left and a depletion 
of oxidised substances to the right of the 
block. T h e  substances involved can be 
measured in both their oxidized and reduced 
state in the presence o f a barbiturate in the 
metabolic pathway. Therefore the site of 
block in the chain can be determined by the 
point at which the transition between elev­
ation of the reduced proportion and depletion 
of the oxidized proportion of such substances 
occurs. This is then the site o f action of the 
barbiturate.
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Chance and H ollinger showed a build up 
of reduced N A D P H 2 and a depletion of oxid­
ized cytochrome b in the presence of bar­
biturate and concluded that its site of action 
m ust be between N A D P H 2 and F A D  cyt. b 
(Site I in diagram). I f  the site of action had 
been site I I  then they would have observed an 
accumulation of reduced cyt. b  and depletion 
of oxidized cyt. c.
Glucose
I Barbiturate block
I
I
reduced
It  can be concluded that barbiturates pre­
vent respiration of liver mitochondria by in­
hibition of the m etabolism at the site shown 
(N A D P H2/cyt. b).
T h is is very satisfying biochem ically, but all 
this work was done in vitro, a long way from 
the com plicated structure and mechanism of 
whole brain. Does barbiturate have the same 
action in whole brain?
W e  designed an experim ent on the hypo­
thesis that barbiturates have the same site of 
action in vivo and in vitro. I t  involved 
anaesthetising rats with a barbiturate and 
giving them a substrate, metabolised in  brain, 
which enters the pathway before the proposed 
site of action (we used pyruvate), and one that 
enters after the proposed site of action (we 
used succinate). W e  observed.
Th is sounds easy. However, the difficulties 
in administering substances to the brain in 
known concentration are great. T h e  sub­
stances we used, pyruvate, succinate, are utiliz­
ed by other tissues in  the body; they are also 
highly ionized and 'therefore will not easily 
cross the so-called blood-brain barrier.
Recently new techniques have been develop­
ed to overcome such difficulties, some of great 
sophistication; we used a rather crude but 
effective technique.
Once the rat is anaesthetized by an intra- 
peritoneal injection of barbiturate, a small hole 
is bored at a particular point on the skull. 
Substances are then injected in small volumes 
into one of the lateral ventricle o f the brain,
through a special needle so designed that the 
depth from guard to tip is the depth required 
to reach the lateral ventricle in rats of a certain 
weight.
Using this technique the experim ent was 
elaborated using three groups of rate of the 
same age, sex and weight. O ne group received 
standard dose of barbiturate alone, one group 
barbiturate and intraventricular succinate and
ATP
II
oxidised
the other group barbiturate and intra­
ventricular pyruvate. T h e  sleeping times of 
all rats, that is the time from onset of anaes­
thesia to time of arousal, were determined. 
O ther variables were eliminated by using
(1) Rats of the same strain and weight and 
receiving a  standard dose o f barbiturate 
I.P.
(2) Starved rats, so that absorption from peri­
toneum would be more predictable.
(3) M ale rats since Brody has shown that bar­
biturates have different lengths of action 
in different sexes.
T h e  results were striking. T h ere  was no 
significant difference in the control group and 
the group given pyruvate; both groups having 
sleeping times o f around 100 minutes. H ow ­
ever, the group receiving succinate had a mean 
sleeping time of around 30 minutes. T h is is 
a highly significant difference.
It  can be argued that succinate in some way 
decreased the concentration o f available bar­
biturate either by increasing its m etabolism or 
by inactivating it. In order to eliminate this 
possibility, samples of blood were collected 
from all rats by decapitation at the time of 
arousal. T h e  blood barbiturate levels were 
estimated. T h e  levels in the blood of the 
succinate group killed at around 30 minutes 
were found to be significantly higher than the 
levels in the control and pyruvate group killed 
around 100 minutes. Th is was to be expected 
if the succinate did not affect the barbiturate 
blood level and it was concluded that the
action of succinate must be central in the 
brain. (Intra cellular oxidation at reversal 
level).
From  these results we can postulate that our 
original hypothesis was correct since, like the 
mitochondria discussed earlier, the rats could 
utilize succinate for energy production, to 
overcome the barbiturate anaesthesia, but were 
not able to utilize pyruvate. W e  therefore 
concluded that the barbiturates act in the 
sim ilar way in whole brain as they do in 
isolated mitochondria.
T h e  question now arises as to whether the 
action of barbiturates cannot be reversed in 
humans, if  succinate can reverse barbiturate 
anaesthesia in rats. T h is seems to be a good 
idea, but I have already mentioned difficulties 
due to blood-brain barrier effects, which would 
exclude the possibility of using succinate 
intravenously. In fact two workers, Soskin and 
Taubenhous, tried this, with no effect, in 1943, 
long before Kregs invented his cycle.
I t  is difficult to persuade anybody that bor­
ing holes in human heads to inject directly 
into brain tissue is of justifiable therapeutic 
value. And the present m ortality rate after 
hospital admission is small, due to the exten­
sive supportive therapy employed in overdose 
treatment.
It has been suggested that we perform 
cysternal punctures in particularly ill patients 
but this is a difficult and not widely practiced 
technique and would be available only to the 
few.
W e  must use an intravenous route of ad­
ministration if this m ethod of treatment is to 
be useful and we must therefore m odify the 
succinate molecule in some way. It occurred 
to us that the answer m ight be to make a 
fat-soluble succinate molecule with the active 
site free. It  could enter the brain and still act 
as a substrate for metabolism. A  substance 
that appeared to have the required physical 
properties was monoethylsuccinate, highly 
soluble in water and organic solvents.
CH. — COOH CH2 — COCH5 
CHa — COOH CH2 — COOH 
succinate m onoethylsuccinate
Finding a recipe to make this substance 
proved to be more difficult. However, we now 
have a whole 50 grams and hope to begin work 
soon. T h e  theory is that this substance will 
enter brain in sufficient concentrations and 
will be split by esterases to give free succinate 
and, incidentally, ethyl alcohol to bring you 
round drunk.
As I have already indicated, barbiturate 
poisoning is a major problem. M uch time and 
money and m any lives could be saved if every 
doctor in the land could wake these sleeping 
beauties with a simple injection.
There is a long way to  go. T his is only the 
beginning.
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